Coxsackieviruses and diabetes

BioEssays

Volumn 19, Issue 9, 1997, Pages 793-800

  Ramsingh, Arlene I ^a   Chapman, Nora ^b   Tracy, Steven ^b  

^a WADSWORTH CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; COXSACKIEVIRUS; ENCEPHALOMYOCARDITIS VIRUS; ENTEROVIRUS;

EID: 0031239261     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.950190909     Document Type: Review

References (85)

1. Eisenbarth, G.S. (1986). Type I diabetes mellitus: A chronic autoimmune disease. N. Engl. J. Med. 314, 1360-1368.
2. Davies, J.L. et al. (1994). A genome-wide search for human type 1 diabetes susceptibility genes. Nature 371, 130-136.
3. Fohlman, J. and Friman, G. (1993). Is juvenile diabetes a viral disease? Ann. Med. 25, 569-574.
4. Mondino, A., Khoruts, A. and Jenkins, M.K. (1996). The anatomy of T-cell activation and tolerance. Proc. Natl Acad. Sci. USA 93, 2245-2252.
5. Goodnow, C.C. (1996). Balancing immunity and tolerance: Deleting and tuning lymphocyte repertoires. Proc. Natl Acad. Sci. USA 93, 2264-2271.
6. Andre, I., Gonzalez, A., Wang, B., Katz, J., Benoist, C. and Mathis, D. (1996). Checkpoints in the progression of autoimmune disease: lessons from diabetes models. Proc. Natl Acad. Sci. USA 93, 2260-2263.
7. Gianani, R. and Sarvetnick, N. (1996). Viruses, cytokines, antigens, and autoimmunity. Proc. Natl Acad. Sci. USA 93, 2257-2259.
8. Kappler, J.W., Roehm, N. and Marrack, P. (1987). T cell tolerance by clonal elimination in the thymus. Cell 49, 273-280.
9. Kappler, J.W., Staerz, U.D., White, J. and Marrack, P. (1988). Self tolerance eliminates T cells specific for Mls-modified products of the major histocompatibility complex. Nature 332, 35-40.
10. Ramsdell, F., Lantz, T. and Fowlkes, B.J. (1989). A nondeletional mechanism of thymic self tolerance. Science 246, 1038-1041.
11. a. Nature 345, 540-542.
12. Haskins, K., Portas, M., Bergman, B., Lafferty, K. and Bradley, B. (1989). Pancreatic islet-specific T cell clones from nonobese diabetic mice. Proc. Natl Acad. Sci. USA 86, 8000-8004.
13. Bergman, B. and Haskins, K. (1994). Islet-specific T cell clones from the NOD mouse respond to beta granule antigen. Diabetes 43, 197-203.
14. Katz, J.D., Wang, B., Haskins, K., Benoist, C. and Mathis, D. (1993). Following a diabetogenic T cell from genesis through pathogenesis. Cell 74, 1089-1100.
15. Higuchi, Y. et al. (1992). Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes. J. Exp. Med. 176, 1719-1731.
16. Picarella, D.E., Kratz, A., Li, C., Ruddle, N.H. and Flavell, R.A. (1993). Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. J. Immunol. 150, 4136-4150.
17. Scott, B. et al. (1994). A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity. Immunity 1, 73-83.
18. Steinman, L. (1996). A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: A tale of smart bombs and the infantry. Proc. Natl Acad. Sci. USA 93, 2253-2256.
19. Rueckert, R.R. (1996). Picornaviridae and their replication. In Fundamental Virology (ed. B.N. Fields et al.), pp. 477-522. Lippincott-Raven, Philadelphia.
20. Barrett-Connor, E. (1985). Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence. Rev. Infect. Dis. 7, 207-215.
21. Yoon, J. (1995). A new look at viruses in type 1 diabetes. Diabetes/Metabolism Reviews 11, 83-107.
22. Grist, N.R., Bell, E.J. and Assaad, F. (1978). Enteroviruses in human disease. Prog. Med. Virol. 24, 114-157.
23. Melnick, J.L. (1985). Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In Virology (ed. B.N. Fields et al.), pp. 739-794. Raven Press, New York.
24. Tracy, S., Chapman, N.M., Romero, J. and Ramsingh, A.I. (1996). Genetics of coxsackievirus B cardiovirulence and inflammatory heart muscle disease. Trends Microbiol. 4, 175-179.
25. Zsofia, O., Deak, J. and Pap, A. (1992). Possible role of coxsackie-B virus infection in pancreatitis. Int. J. Pancreatology 11, 105-108.
26. Jenkins, O., Booth, J., Minor, P. and Almond, J. (1987). The complete nucleotide sequence of coxsackievirus B4 and its comparison to other members of the Picornaviridae. J. Gen. Virol. 68, 1835-1848.
27. Szopa, T.M., Titchener, P.A., Portwood, N.D. and Taylor, K.W. (1993). Diabetes mellitus due to viruses - some recent developments. Diabetologia 36, 687-695.
28. D'Alessio, D.J. (1992). A case-control study of group B coxsackievirus immunoglobulin M antibody prevalence and HLA-DR antigens in newly diagnosed cases of insulin-dependent diabetes mellitus. Amer. J. Epidemiol. 135, 1331-1338.
29. Svejgaard, A., Platz, P. and Ryder, L.P. (1983). HLA and disease 1982 - a survey. Immunol. Rev. 70, 193-218.
30. Cohen, D. et al. (1984). Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis. Proc. Natl Acad. Sci. USA 81, 1774-1778.
31. Cohen-Haguenauer, O. et al. (1985). A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus. Proc. Natl Acad. Sci. USA 82, 3335-3339.
32. Todd, J.A., Bell, J.I. and McDevitt, H.O. (1987), HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329, 599-604.
33. Todd, J.A., Bell, J.I. and McDevitt, H.O. (1988). A molecular basis for genetic susceptibility to insulin-dependent diabetes mellitus. Trends Genet. 4, 129-134.
34. Yoon, J., Austin, M., Onodera, T. and Notkins, A.L. (1979) Virus-induced diabetes mellitus: Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N. Eng. J. Med. 300, 1173-1179.
35. Champsaur, H.F., Bottazzo, G.F., Bertrams, J., Assan, R. and Bach, C. (1982). Virologic, immunologic, and genetic factors in insulin-dependent diabetes mellitus. J. Pediatr. 100, 15-20.
36. Lansdown, A.B.G. (1976). Pathological changes in the pancreas of mice following infection with coxsackie B viruses. Br. J. Exp. Path. 57, 331-338.
37. Ross, M.E., Hayashi, K. and Notkins, A.L. (1974). Virus-induced pancreatic disease: alteration in concentration of glucose and amylase in blood. J. Infect. Dis. 129, 669-676.
38. Vella, C., Brown, C.L. and McCarthy, D.A. (1992). Coxsackievirus B4 infection of the mouse pancreas: Acute and persistent infection. J. Gen. Virol. 73, 1387-1394.
39. q locus of the major histocompatibility complex. Virus Res. 14, 347-358.
40. Caggana, M., Chan, P. and Ramsingh, A. (1993). Identification of a single amino acid residue in the capsid protein VP1 of Coxsackievirus B4 that determines the virulent phenotype. J. Virol. 67, 4797-4803.
41. Kibrick, S. and Benirschke, K. (1958) Severe generalized disease (encephalohepatomyocarditis) occurring in newborn period and due to infection with coxsackie virus, group B. Pediatrics 22, 857-875.
42. Toniolo, A., Onodera, T., Jordan, G.W., Yoon, J. and Notkins, A.L. (1982). Virus-induced diabetes mellitus: Glucose abnormalities produced in mice by the six members of the coxsackie B virus group. Diabetes 31, 496-499.
43. Yoon, J., Onodera, T. and Notkins, A.L. (1978). Virus-induced diabetes mellitus: Beta cell damage and insulin-dependent hyperglycemia in mice infected with Coxsackie virus B4. J. Exp. Med. 148, 1068-1080.
44. Kuno, S., Itagaki, A., Yamazaki, I., Katsumoto, T. and Kurimura, T. (1984). Pathogenicity of newly isolated coxsackievirus B4 for mouse pancreas. Acta Virol. 28, 433-436.
45. Szopa, T.M., Ward, T., Dronfield, D.M., Portwood, N.D. and Taylor, K.W. (1990). Coxsackie B4 viruses with the potential to damage beta cells of the islets are present in clinical isolates. Diabetologia 33, 325-328.
46. Webb, S.R., Loria, R.M., Madge, G.E. and Kibrick, S. (1976). Susceptibility of mice to group B coxsackievirus is influenced by the diabetic gene. J. Exp. Med. 143, 1239-1248.
47. Webb, S.R., Loria, R.M. and Kibrick, S. (1979). Coxsackievirus B infection in the mouse - effects associated with the diabetic gene, db. Curr. Microbiol. 3, 15-19.
48. Chatterjee, N.K., Haley, T.M. and Nejman, C. (1985). Functional alterations in pancreatic cells as a factor in virus-induced hyperglycemia in mice. J. Biol. Chem. 260, 12786-12791.
49. Kang, Y., Chatterjee, N.K., Nodwell, M.J. and Yoon, J. (1994). Complete nucleotide sequence of a strain of coxsackie B4 virus of human origin that induces diabetes in mice and its comparison with nondiabetogenic coxsackie B4 JBV strain. J. Med. Virol. 44, 353-361.
50. Ramsingh, A.I. and Collins, D.N. (1995). A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence. J. Virol. 69, 7278-7281.
51. Klump, W.M., Bergmann, I., Muller, B.C., Ameis, D. and Kandolf, R. (1990). Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: Two initial 5′ uridine residues are regained during plus-strand RNA synthesis. J. Virol. 64(4), 1573-1583.
52. Ramsingh, A., Araki, H., Bryant, S. and Hixson, A. (1992) Identification of candidate sequences that determine virulence in Coxsackievirus B4. Virus Res. 23, 281-292.
53. Titchener, P.A., Jenkins, O., Szopa, T.M., Taylor, K.W. and Almond, J.W. (1994). Complete nucleotide sequence of a beta-cell tropic variant of coxsackievirus B4. J. Med. Virol. 42, 369-373.
54. See, D.M. and Tilles, J.G. (1995). Pathogenesis of virus-induced diabetes in mice. J. Infect. Dis. 171, 1131-1138.
55. Chatterjee, N.K., Hou, J., Dockstader, P. and Charbonneau, T. (1992). Coxsackievirus B4 infection alters thymic, splenic, and peripheral lymphocyte repertoire preceding onset of hyperglycemia in mice. J. Med. Virol. 38, 124-131.
56. Baekkeskov, S., Neilsen, J.H., Marner, B., Bilde, T., Ludvigsson, J. and Lernmark, Å. (1982). Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 298, 167-169.
57. Baekkeskov, S. et al. (1990). Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 347, 151-156.
58. Kaufman, D.L. et al. (1992). Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 89, 283-292.
59. r autoantigen and glucose sensitivity of islets before development of hyperglycemia. Diabetes 37, 1419-1425.
60. Oldstone, M.B.A. (1987). Molecular mimicry and autoimmune disease. Cell 50, 819-820.
61. Tian, J., Lehmann, P.V. and Kaufman, D.L. (1994). T cell cross-reactivity between coxsackievirus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J. Exp. Med. 180, 1979-1984.
62. Craighead, J.E. and McLane, M.F. (1968). Diabetes mellitus: induction in mice by encephalomyocarditis virus. Science 162, 913-914.
63. Yoon, J., McClintock, P.R., Onodera, T. and Notkins, A.L. (1980). Virus-induced diabetes mellitus. XVIII. Inhibition by a nondiabetogenic variant of encephalomyocarditis virus. J. Exp. Med. 152, 878-892.
64. Bae, Y.S. and Yoon, J. (1993). Determination of diabetogenicity attributable to a single amino acid, Ala776, on the polyprotein of encephalomyocarditis virus. Diabetes 42, 435-443
65. Luo, M., Vriend, G. et al. (1987). The atomic structure of Mengo virus at 3.0 Å resolution. Science 235, 182-191.
66. Craighead, J.E. (1976). Virus induced insulitis in experimental animal models. Acta Endocrinol. Suppl. Copenh. 205, 123-128.
67. Yoon, J. and Notkins, A.L. (1976). Virus-induced diabetes mellitus. VI. Genetically determined host differences in the replicating of encephalomyocarditis virus in pancreatic beta cells. J. Exp. Med. 143, 1170-1185.
68. Kaptur, P.E., Thomas, D.C. and Giron, D.J. (1989). Differing attachment of diabetogenic and nondiabetogenic variants of encephalomyocarditis virus to beta-cells. Diabetes 38, 1103-1108.
69. Huber, S.A. (1994). VCAM-1 is a receptor for encephalomyocarditis virus on murine vascular endothelial cells. J. Virol. 68, 3453-3458.
70. Pelletier, R.P. et al. (1993). Analysis of inflammatory endothelial changes, including VCAM-1 expression, in murine cardiac grafts. Transplantation 55, 315-320.
71. Buschard, K., Rygaard, J. and Lung, E. (1976). The inability of a diabetogenic virus to induce diabetes mellitus in athymic (nude) mice. Acta Pathol. Microbiol. Scand. C 84, 299-303.
72. Buschard, K., Hastrup, N. and Rygaard, J. (1983). Virus-induced diabetes mellitus in mice and the thymus-dependent immune system. Diabetologia 24, 42-46.
73. Barger, M.T. and Craighead, J.E. (1991). Immunomodulation of encephalomyocarditis virus-induced disease in A/J mice. J. Virol. 65, 2676-2681.
74. Yoon, J., McClintock, P.R., Bachurski, C.J., Longstreth, J.D. and Notkins, A.L. (1985). Virus-induced diabetes mellitus. No evidence for immune mechanisms in the destruction of beta-cells by the D-variant of encephalomyocarditis virus. Diabetes 34, 922-925.
75. Baek, H.S. and Yoon, J. (1990). Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice. J. Virol. 64, 5708-5715.
76. Hirasawa, K., Takeda, M., Itagaki, S. and Doi, K. (1996). Involvement of macrophages in the development of encephalomyocarditis (EMC) virus-induced diabetes in mice. Exp. Anim. 45, 77-80.
77. Babu, P.G., Huber, S.A. and Craighead, J.E. (1986). Contrasting features of T-lymphocyte-mediated diabetes in encephalomyocarditis virus-infected Balb/cBy and Balb/cCum mice. Am. J. Pathol. 124(2), 193-198.
78. Bigley, N.J., Blay, R. and Smith, R.A. (1987). Impaired cytokine response in male ICR Swiss mice after infection with D variant of encephalomyocarditis virus. Diabetes 36, 1408-1413.
79. Hirasawa, K., Ogiso, Y., Takeda, M., Lee, M.J., Itagaki, S. and Doi, K. (1995). Protective effects of macrophage-derived interferon against encephalomyocarditis virus-induced diabetes mellitus in mice. Lab. Anim. Sci. 45, 652-656.
80. Baek, H.S. and Yoon, J. (1991). Direct involvement of macrophages in destruction of beta-cells leading to development of diabetes in virus-infected mice. Diabetes 40, 1586-1597.
81. Jordan, G.W. and Cohen, S.H. (1987). Encephalomyocarditis virus-induced diabetes mellitus in mice: model of viral pathogenesis. Rev. Infect. Dis. 9, 917-924.
82. Ishikawa, R. and Bigley, N.J. (1990). Sex hormone modulation of interferon (IFN) alpha/beta and gamma production by mouse spleen cell subsets following picornavirus infection. Viral Immunol. 3, 225-236.
83. Giron, D.J. and Yei, S. (1993). Interference by a non-interferon-inducing subvariant of benign encephalomyocarditis virus-B with the ability of EMCV-D to produce insulin-dependent diabetes mellitus in ICR Swiss male mice. J. Interferon Res. 13, 363-368.
84. Wucherpfennig, K.W. and Strominger, J.L. (1995). Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 80, 695-705.
85. Coleman, T.J., Taylor, K.W. and Gamble, D.R. (1974) The development of diabetes following Coxsackie B virus infection in mice. Diabetologia 10, 753-759.